Rick received his Chemistry PhD in 1989 and was a NIH post-doctoral fellow at Harvard with Professor E.J. Corey. He began his career as a bench chemist at Bayer prior to joining Pfizer as a head of Cancer Chemistry in 1999. He presently leads the External Research Solutions group in Groton, CT: a group that integrates and aligns a network of CROs, biotech and academic groups to support delivery of the research portfolio at Pfizer.
Dr. Derek Lowe
Derek has worked on a variety of drug discovery projects since starting in the industry in 1989 at Schering-Plough. After several years at Bayer, he is now a member of an exploratory biochemistry team at Vertex. His web site (“In the Pipeline”) is a widely read source of pharma news and opinion.
Dr. Nicholas Meanwell
Dr. Meanwell has a Ph.D, from the U. Sheffield and completed a Postdoctoral Fellowship at Wayne State University. He joined Bristol-Myers Squibb in 1982 and has led the antiviral chemistry group since 1992. They have pioneered several mechanistically novel antiviral approaches including influenza and respiratory syncytial virus fusion inhibitors, HIV-1 attachment inhibitors and HCV NS5A inhibitors. They have also completed Phase 3 clinical trials of a combination of the HCV NS5A inhibitor daclatasvir and the HCV NS3 inhibitor asunaprevir.
Molly B. Schmid, Ph.D. is currently a Senior Counselor for TriTech Small Business Development Center, President of the Inland Empire network of the Tech Coast Angels and a member of the TCA Board of Directors. Part of her career was in academia, as Professor and Entrepreneur-in-Residence at Keck Graduate Institute of Applied Life Sciences in Claremont CA and Assistant Professor of Molecular Biology at Princeton University. She also held senior leadership positions in the biotech industry, as Senior Vice President of Preclinical Programs at Affinium Pharmaceuticals in Toronto, Director of Genomics and Bioinformatics at Genencor International, and Director of Biology and Vice President of Research Alliances at Microcide Pharmaceuticals. She is a Fellow of the American Academy of Microbiology, a Searle Scholar, and a Damon-Runyon Fellow. Dr. Schmid earned her PhD in biology from the University of Utah and her undergraduate degree in biology from SUNY Albany.